Carrillo ER, Hernández HDA

Idioma: Español
Referencias bibliográficas: 24
Paginas: 193-196
Archivo PDF: 41.73 Kb.

RESUMEN

La hiperglucemia en el enfermo grave se asocia a incremento en la morbimortalidad, costos y estancia hospitalaria. El control estricto de la glucosa mediante la infusión continua de insulina guiada por un protocolo ha demostrado en diferentes trabajos que disminuye de manera significativa los costos, días de estancia hospitalaria, complicaciones y mortalidad. Por lo anterior se hace una revisión de la literatura para actualizar a la comunidad médica sobre este tema.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Umpierrez G, Isaacs S, Bazargan N et al. Hyperglucemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002: 87-972-982.

2. Van Den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.

3. Krinsley JS, Jones R. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006; 129: 3.

4. Van Den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-67.

5. Van Den Berghe G, Wouters P, Kesteloot K et al. Analysis of healthcare resources utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006; 34: 612-616.

6. Capes SE, Hunt D, Klas M et al. Stress hyperglycemia and prognosis of stroke in nondiabetic an diabetic patients: a systemic overview. Stroke 2001; 32: 2426-2432.

7. Demchuk A, Morgestern L, Krieger D et al. Serum glucose level and diabetes predict tissue plasminogen activator –related intracerebral haemorrhage in acute ischemic stroke. Stroke 1999; 30: 34-39.

8. Baird T, Parsons M, Thanh P et al. Persistent post-stroke hyperglucemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208-2214.

9. Robinsn LE, Soeren M. Insulin resistance and hyperglycemia in critical illness. AACN Clinical Issues 2004; 15: 45-62.

10. Van Den Berghe G, Zegher F, Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 13: 1827-34.

11. Van Den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically illness: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366.

12. Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-91.

13. Montory V, Bistrian B, MacMahon M. Hyperglucemia in acutely ill patients. JAMA 2002; 288: 2167-9.

14. Coursin D, Connery E, Ketzler J. Perioperative diabetic and hyperglucemic management issues. Crit Care Med 2004; 32: 4.

15. Solano T, Totaro R. Insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care 2004; 7: 199-205.

16. Preiser J, Devos P, Van Den Berghe G. Tight control of glycaemia in critically ill patient. Curr Opin Nutr Metab Care 2002; 5: 533-7.

17. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycemia. Best Prac Res Clin Endocrinol Metab 2001; 15: 533-51.

18. Goldberg P, Siegel M, Barret PW et al. Implementation of a safe and effective insulin protocol in a medical intensive care unit. Diabetes Care 2004; 27: 773-8.

19. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patient with acute myocardial infarction. J Am Coll Cardiol 1995; 26: 57-65.

20. Mc Cowen K, Malhotra, Bristrian B. Endocrine and metabolic dysfunction syndromes in the critically ill. Stress induced hyperglucemia. Crit Care Clin 2001; 17: 1.

21. Collier B, Diaz J, Forbes R et al. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN 2005; 29: 353-359.

22. Van Den Berghe G. Endocrine evaluation of patients with critical illness. J Clin Endocrinol Metab 2003; 32: 2.

23. Van Den Berghe G, Schoonnheydt K, Bruyninckx F et al. Insulin therapy protects the central an peripheral nervous system of intensive care patients. Neurology 2005; 64: 1348-1353.

24. Van Den Berghe G, Wouters PJ, Kesteloot K et al. Analysis of healthcare resources utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006; 34: 612–616.